Valuation: Novoprotein Scientific Inc.

Market Cap 8.9B 1.33B 1.17B 1.1B 1B 1.88B 127B 1.89B 13.21B 5.1B 65.06B 4.98B 4.87B 209B P/E 2024
-42.6x
P/E 2025 -36.1x
Enterprise Value 7.25B 1.08B 950M 899M 815M 1.53B 104B 1.54B 10.75B 4.15B 52.97B 4.06B 3.97B 170B EV / Sales 2024
4.57x
EV / Sales 2025 7.78x
Free-Float
30.99%
Yield 2024 *
-
Yield 2025 -
1 day+2.26%
1 week+29.33%
Current month+86.24%
1 month+54.97%
3 months+280.40%
6 months+219.80%
Current year+219.80%
1 week 115.8
Extreme 115.8
135.61
1 month 59
Extreme 59
135.61
Current year 33.2
Extreme 33.2
135.61
1 year 33.2
Extreme 33.2
135.61
3 years 28.56
Extreme 28.56
135.61
5 years 28.56
Extreme 28.56
135.61
10 years 28.56
Extreme 28.56
135.61
Manager TitleAgeSince
Chief Executive Officer 54 2009-09-06
Director of Finance/CFO 53 2013-06-30
Chief Tech/Sci/R&D Officer 36 2015-06-30
Director TitleAgeSince
Chairman 54 2009-09-06
Director/Board Member 54 2019-01-31
Director/Board Member 41 2021-04-14
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%+29.33%+199.32%+149.91% 1.3B
-0.80%+28.07%+705.55%+98.39% 79.4B
-4.54%-4.15%+33.40%-9.65% 78.69B
+2.80%+3.60%-6.34%-27.82% 59.52B
-0.89%+2.11%+7.92%+170.43% 46.58B
+2.49%+0.14%-8.95%+33.71% 46.53B
+0.48%+6.12%+66.48%-11.20% 33.63B
+0.75%-0.39%+50.93%+111.17% 25.11B
-3.56%-0.47%+3.11%+135.37% 22.13B
+0.73%-1.70%+61.19%+100.64% 15.31B
Average +0.06%+4.65%+111.26%+75.09% 40.82B
Weighted average by Cap. -0.35%+6.72%+154.35%+54.02%

Financials

2024 2025
Net sales 128M 19.01M 16.72M 15.82M 14.34M 26.95M 1.82B 27.09M 189M 73.02M 932M 71.36M 69.82M 2.99B 146M 21.82M 19.2M 18.16M 16.47M 30.93M 2.09B 31.1M 217M 83.83M 1.07B 81.93M 80.16M 3.44B
Net income -54.42M -8.11M -7.13M -6.75M -6.12M -11.5M -778M -11.56M -80.71M -31.15M -398M -30.44M -29.79M -1.28B -77.78M -11.59M -10.2M -9.64M -8.75M -16.43M -1.11B -16.52M -115M -44.52M -568M -43.52M -42.58M -1.82B
Net Debt -1.73B -259M -227M -215M -195M -366M -24.81B -368M -2.57B -993M -12.68B -971M -950M -40.7B -1.65B -247M -217M -205M -186M -349M -23.66B -351M -2.45B -947M -12.09B -926M -906M -38.81B
Logo Novoprotein Scientific Inc.
Novoprotein Scientific Inc is a China-based company mainly engaged in the provision of recombinant protein application solutions. The Company’s main businesses include the research and development, production and sales of target and factor proteins, recombinant antibodies, enzymes and reagents, and the provision of full process application solutions in the fields of biopharmaceuticals, in vitro diagnostics, and basic research in life sciences. The Company's main products include novel coronavirus diagnostic antibodies, novel coronavirus diagnostic antigens, novel coronavirus pseudoviruses, novel coronavirus non-structural proteins and messenger ribonucleic acid (mRNA) raw materials enzymes and reagents. Its products and services are mainly used in biological medicine, basic research of life science, in vitro diagnosis, mRNA vaccine drugs and other fields. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
696
Date Price Change Volume
26-09-28 CN¥128.08 +2.26% 8,487,401
26-09-24 CN¥125.25 +1.96% 8,042,989
26-09-23 CN¥122.84 -1.33% 8,950,843
26-09-22 CN¥124.50 +4.76% 12,290,599
  1. Stock Market
  2. Stocks
  3. 688137 Stock